Friday, October 2, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 25, 2026

Earnings live: Circle stock soars, First Solar and Lowe's fall on guidance misses

View original at finance.yahoo.com
Earnings live: Circle stock soars, First Solar and Lowe's fall on guidance misses Fourth quarter earnings season is entering its final stretch…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Domino's share on DoorDash expected to grow as awareness and marketing spend increases, representing meaningful opportunity as fair share not yet reached on major aggregators

    80% confidence
  • Q4 results were largely in-line with expectations, reflecting lack of storm activity and ongoing consumer uncertainty in housing, with underlying demand relatively stable throughout the year when adjusting for storms

    80% confidence
  • Growth journey continued into 2025 with commissioning of Louisiana factory and decision to establish South Carolina facility while maintaining disciplined approach to contracting and pricing certainty

    80% confidence
  • Early reaction with shares down low-single digits makes sense with results and guidance in-line to slightly below expectations

    80% confidence
  • MORE strategy delivered higher sales and profits, showcasing ability to drive store level profitability while providing incredible value for customers

    80% confidence
  • Adding approximately 1.1 million net new members in 2025 highlights incredible demand for the brand after 50% price increase

    80% confidence
  • While housing macro remains pressured, company is focused on productivity initiatives and well-positioned to take share regardless of macro environment

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com
Earnings live: Circle stock soars, First Solar and Lowe's fall on guidance misses — Source | Via News | Finance Via News